Karyopharm Therapeutics

karyopharm.com

Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company focused on pioneering novel cancer therapies, particularly through its industry-leading oral Selective Inhibitor of Nuclear Export (SINE) technology. The company aims to address high unmet needs in cancer treatment by developing innovative drugs for various tumor types, including hematologic and solid tumors. Karyopharm's commitment to scientific innovation and patient-centric approach positions it as a leader in the oncology space, with ongoing clinical trials for its lead drug candidate and next-generation programs.